Potential Side Effects Linked to Receptor Activity The most common side effects in phase 2 trials were gastrointestinal, including nausea, vomiting, and diarrhoea, consistent with GLP-1R agonist class effects
Symptoms related to stomach paralysis, including nausea, vomiting, and feeling full after eating, are very similar to the expected effects of semaglutide
Semaglutide is primarily approved by the FDA (Food and Drug Administration) for the treatment of type 2 diabetes
They are not FDA-approved but are legal and clinically monitored
Months 26 : Active Therapy Monthly Monitoring: Track Quality, Not Just Quantity
For years, it was all about diet, exercise and lifestyle